Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma.
Plzák
Jan
J
Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Faculty Hospital Motol, V úvalu 84, 150 06 Prague 5, Czech Republic. jan.plzak@lf1.cuni.cz
Betka
Jan
J
Smetana
Karel
K
Chovanec
Martin
M
Kaltner
Herbert
H
André
Sabine
S
Kodet
Roman
R
Gabius
Hans-Joachim
HJ
D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000378:metabolism*; D005260:Female; D005500:Follow-Up Studies; D037502:Galectin 3 / Q000378:metabolism*; D006258:Head and Neck Neoplasms / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016019:Survival Analysis
D037502:Galectin 3